Fimepinostat - An Overview
A period I research in Japanese people with R/R NHL, such as ATLL individuals, confirmed a workable basic safety profile, and forty mg twice each week was selected for subsequent medical growth.These preclinical observations help the speculation that tucidinostat will likely be efficacious in ATLL.The examine cohort integrated Japanese adult clie